PRESS CENTRE/LATEST INFORMATION
All information on our Company’s activities in one place

News

PRESS CENTAR / NEWS
Bosnalijek for the 21st Century
On Wednesday 28 March, Bosnalijek d.d. (Bosnalijek), the leading pharmaceutical company in Bosnia and Herzegovina, inaugurated a new Quality Control facility in Sarajevo.
MORE
ANNUAL REGULAR ASSEMBLY
Notice of convening annual regular assembly of Bosnalijek joint stock company
Pursuant to Article 230, paragraph (1) of Company Law (Official Gazette of FB&H, No. 81/15) and Article 48, paragraph (1) of valid Bosnalijek d.d. Statute (consolidated text No: 2830/2017 of 18.09.2017), and based on the Supervisory Board's Decision on Convening Annual Regular Assembly No. 1909/18 of 28.05.2018, we announce:
Read more
PRESS CENTAR / NEWS
Bosnalijek for the 21st Century
On Wednesday 28 March, Bosnalijek d.d. (Bosnalijek), the leading pharmaceutical company in Bosnia and Herzegovina, inaugurated a new Quality Control facility in Sarajevo.
Read more
Previous news
Postgraduate Students from the American University Yale visit Bosnalije ... Bosnalijek achieves Record Turnover of 107 million BAM in Foreign Market ... Memento – Little Dementia School The First Regional Cardiology Case Report Award Competition (CCRAC 2017 ... Continuous Growth: Bosnalijek Revenue increases by 35 per cent in 2017 Bosnalijek Wins Prestigious Award: Lysobact No. 1 in Sore Throat Remedie ... Together for Clean Waters in Bosnia and Herzegovina Bosnalijek Donates New Equipment to the Spid Swimming Club Notification - Proposals of candidates for members of Bosnalijek d.d. Su ... Bosnalijek Gold Sponsor of the Fifth Conference of the Association of Ge ... Notice of Reconvened Annual General Assembly of Bosnalijek d.d. Bosnalijek Hosts its Traditional Luncheon for Retired Employees Annual General Assembly of Bosnalijek d.d. - NOTIFICATIONS Excellent Sales Results on the Russian Market Recapitalisation enabled New Investment in and the further Development o ... Bosnalijek hosts Students from the American University Yale Bosnalijek saw Revenue and Profit Increase in 2016 Announcement of the Fifth (V) Issuance of Shares through a Closed Offeri ... Lysobact Celebrates 40th Anniversary Some Wishes do come True at once
oktobar 21. 2018 |
SASE |
BSNLR - Bosnalijek d.d. Sarajevo: 12,47 3,89%